SCHEMBL19783248

SCHEMBL19783248

COc1c(F)cc(F)c2nc(N)sc12

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
LMNA P02545 1/20 0.42
CYP3A4 P08684 2/20 0.39
HTT P42858 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
HSD17B10 Q99714 3/20 0.38
ILK Q13418 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
ADORA1 P30542 1/20 0.35
HPGD P15428 1/20 0.34
PDGFRB P09619 1/20 0.32
PDGFRA P16234 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30189744 1.00 ALDH1A1 (0.42) ALDH1A1LMNACYP3A4HTTTDP1
SCHEMBL21901453 0.86 ALDH1A1 (0.42) ALDH1A1LMNACYP3A4HTTTDP1
Bromide SCHEMBL29611798 0.85 ALDH1A1 (0.41) ALDH1A1LMNACYP3A4HTTTDP1
Bromide SCHEMBL21839505 0.85 ALDH1A1 (0.41) ALDH1A1LMNACYP3A4HTTTDP1
Bromide SCHEMBL21839504 0.83 ALDH1A1 (0.40) ALDH1A1LMNACYP3A4HTTTDP1
SCHEMBL30189678 0.81 ALDH1A1 (0.49) ALDH1A1ILKPDGFRBPDGFRA
SCHEMBL19783083 0.81 ALDH1A1 (0.49) ALDH1A1ILKPDGFRBPDGFRA
SCHEMBL12804043 0.76 CYP3A4 (0.50) ALDH1A1LMNACYP3A4HTTTDP1
SCHEMBL27051926 0.75 CYP3A4 (0.40) ALDH1A1LMNACYP3A4HTTTDP1
SCHEMBL35211926 0.75 ALDH1A1 (0.44) ALDH1A1LMNAHTTTDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2021-06-03 US disclosed
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BISTOL MYERS SQUIBB COMPANY (US) 2019-09-26 US disclosed
WO-2018013774-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, PF4 ALDH1A1 1618/4885LMNA 745/4885CYP3A4 15/4885
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, F12 ALDH1A1 1598/4885LMNA 603/4885CYP3A4 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.